Tango Therapeutics TNGX
NASDAQ TNGX
$24.30 +1.56 (+6.86%)
At close: Nov 10, 2026 · 4:00 PM EST

Tango Therapeutics (TNGX) Total Non-Current Liabilities (2020)

Updated

Tango Therapeutics (TNGX) recorded Total Non-Current Liabilities of $168.65 million in Q4 2020, up 45.8% from the prior quarter.

Analysis

Tango Therapeutics (TNGX) Total Non-Current Liabilities (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 60.81 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 102.65 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 117.60 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 79.95 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 33.91 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 36.05 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 96.04 Bn
10 Tango Therapeutics 3.58 Bn 1.69 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 168.65 Mn
Sep 30, 2020 115.64 Mn
API Access

Tango Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=TNGX&period=max&api_key=YOUR_API_KEY